Venous thrombosis in patients with high-grade glioma.

Date publication

novembre 2015

Journal

Current opinion in oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr TAILLANDIER Luc

Tous les auteurs :
Taillibert S, Taillandier L, Le Rhun E

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/26447877

Résumé

High-grade glioma (HGG) patients are at particularly high risk of venous thromboembolism (VTE) occurrence and recurrence. VTE is associated with worsened survival in these patients. At present, the main challenge when prescribing anticoagulants in HGG patients is to address the risk of intracranial hemorrhage and provide the optimal treatment.

Mots clés

Anticoagulants, adverse effects, Antineoplastic Agents, therapeutic use, Biomarkers, analysis, Brain Neoplasms, complications, Glioma, complications, Humans, Incidence, Intracranial Hemorrhages, chemically induced, Risk Factors, Venous Thromboembolism, diagnosis

Référence

Curr Opin Oncol. 2015 Nov;27(6):516-21